Andy Davis

Andy Davis holds significant leadership experience in the pharmaceutical industry, currently serving as the Vice President and Cardiovascular/Metabolic Franchise Head at Arrowhead Pharmaceuticals. Previously, Andy held the position of Vice President, Global Hematology Marketing and Access Lead at Sobi - Swedish Orphan Biovitrum AB. At Amgen, Andy advanced through several roles, including Executive Director, Global Marketing Lead & Global Product General Manager for Cardiovascular, along with other key leadership positions focused on cardiovascular marketing and global product strategy. Earlier in the career, Andy was a Senior Analyst in the Global Healthcare Practice at Mitchell Madison Group.